Prevalence and Risk Factors for Pulmonary Embolism in Patients with Suspected Acute Exacerbation of COPD: a Multi-center Study
Overview
Authors
Affiliations
Introduction: Pulmonary embolism (PE) prevalence in acute exacerbations of COPD is highly variable.
Methods: To investigate the prevalence and risk factors of PE in patients hospitalized in Departments of Internal Medicine because of AECOPD and suspected PE we conducted a retrospective multicenter study in patients with an AECOPD undergoing chest angio-computed tomography (angio-CT) because of clinical suspect of PE.
Results: 1043 patients (mean age 75.8 years ± 9.7 years, 34.5 % women) were included; 132 patients had PE (mean prevalence 12.66%, 95% confidence interval 10.73, 14.77%).) confirmed by angio-CT and 54 patients died during hospitalization (5.18 %). At multivariate analysis, age, female gender, clinical signs and symptoms suggestive of deep vein thrombosis, hypertension, PaCO ≤ 40 mmHg, and normal chest-x-ray were significantly associated with a higher PE prevalence. Prevalence of PE in patients with 0, 1, 2, 3 or ≥4 risk factors progressively increase from 1.76 to 30.43%. Mean length of hospitalization (LOH) (15.7 vs 14.2 days, p 0.07) and in-hospital mortality (6.1% vs 5.1%, P=0.62) were slightly but not significantly higher in in patients with PE (6.1% vs 5.1%, P=0.62).
Conclusions: PE prevalence is not negligible in this setting. A number of risk factors may help clinicians in identification of patients at increased risk of PE.
Mai V, Girardi L, de Wit K, Castellucci L, Aaron S, Couturaud F BMJ Open. 2024; 14(6):e085328.
PMID: 38904133 PMC: 11191811. DOI: 10.1136/bmjopen-2024-085328.
Rastoder E, Kamstrup P, Hedsund C, Jordan A, Sivapalan P, Romer V Int J Mol Sci. 2024; 25(4).
PMID: 38396728 PMC: 10889576. DOI: 10.3390/ijms25042051.
Liu X, Jiao X, Gong X, Nie Q, Li Y, Zhen G Int J Chron Obstruct Pulmon Dis. 2023; 18:907-917.
PMID: 37223656 PMC: 10202142. DOI: 10.2147/COPD.S410954.
Han W, Wang M, Xie Y, Ruan H, Zhao H, Li J Front Cardiovasc Med. 2022; 9:732855.
PMID: 35355978 PMC: 8959435. DOI: 10.3389/fcvm.2022.732855.
Malli F, Dimeas I, Sinis S, Karetsi E, Nana P, Kouvelos G Medicina (Kaunas). 2022; 58(3).
PMID: 35334597 PMC: 8953859. DOI: 10.3390/medicina58030421.